BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16542695)

  • 1. Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway.
    Managlia EZ; Landay A; Al-Harthi L
    Virology; 2006 Jul; 350(2):443-52. PubMed ID: 16542695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S; Delfraissy JF; Theze J
    Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection of primary human T cells is determined by tunable thresholds of T cell activation.
    Oswald-Richter K; Grill SM; Leelawong M; Unutmaz D
    Eur J Immunol; 2004 Jun; 34(6):1705-14. PubMed ID: 15162441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells.
    Cicala C; Arthos J; Censoplano N; Cruz C; Chung E; Martinelli E; Lempicki RA; Natarajan V; VanRyk D; Daucher M; Fauci AS
    Virology; 2006 Feb; 345(1):105-14. PubMed ID: 16260021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired NFAT transcriptional activity in antigen-stimulated CD8 T cells linked to defective phosphorylation of NFAT transactivation domain.
    Leung-Theung-Long S; Mondor I; Guiraud M; Lamare C; Nagaleekar V; Paulet PE; Rincon M; Guerder S
    J Immunol; 2009 Jun; 182(11):6807-14. PubMed ID: 19454676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helenalin suppresses essential immune functions of activated CD4+ T cells by multiple mechanisms.
    Berges C; Fuchs D; Opelz G; Daniel V; Naujokat C
    Mol Immunol; 2009 Sep; 46(15):2892-901. PubMed ID: 19656571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-18 enhances HIV-1 production in a human chronically-infected T cell line (H9-V).
    Pugliese A; Gennero L; Vidotto V; Speranza F; Tambini R; Torre D
    Cell Biochem Funct; 2002 Dec; 20(4):333-7. PubMed ID: 12415568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment.
    Bento CA; Hygino J; Andrade RM; Saramago CS; Silva RG; Silva AA; Linhares UC; Brindeiro R; Tanuri A; Rosenzwajg M; Klatzmann D; Andrade AF
    AIDS; 2009 Jan; 23(1):9-18. PubMed ID: 19050381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Runx3 inhibits IL-4 production in T cells via physical interaction with NFAT.
    Lee SH; Jeong HM; Choi JM; Cho YC; Kim TS; Lee KY; Kang BY
    Biochem Biophys Res Commun; 2009 Apr; 381(2):214-7. PubMed ID: 19338776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT.
    Sundrud MS; Rao A
    Curr Opin Immunol; 2007 Jun; 19(3):287-93. PubMed ID: 17433870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
    Wittmann M; Killig C; Bruder M; Gutzmer R; Werfel T
    J Leukoc Biol; 2006 Jul; 80(1):75-86. PubMed ID: 16641133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engagement of ICAM-3 provides a costimulatory signal for human immunodeficiency virus type 1 replication in both activated and quiescent CD4+ T lymphocytes: implications for virus pathogenesis.
    Barat C; Gervais P; Tremblay MJ
    J Virol; 2004 Jun; 78(12):6692-7. PubMed ID: 15163761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes.
    Ferrari-Lacraz S; Chicheportiche R; Schneiter G; Molnarfi N; Villard J; Dayer JM
    Int Immunol; 2008 Aug; 20(8):1009-18. PubMed ID: 18556671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.